- Release Date: 01/11/21 08:36
- Summary: US FDA accepts Maxigesic IV(R) New Drug Application
- Price Sensitive: Yes
- Download Document 166.57KB
- Forums
- NZX - By Stock
- AFT
- Ann: US FDA accepts Maxigesic IV(R) New Drug Application
AFT
aft pharmaceuticals limited
Add to My Watchlist
1.14%
!
$2.60

Ann: US FDA accepts Maxigesic IV(R) New Drug Application
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
The Watchlist
FBM
FUTURE BATTERY MINERALS LIMITED
Nick Rathjen, Managing Director and CEO
Nick Rathjen
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online